SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-031901
Filing Date
2023-07-06
Accepted
2023-07-06 08:05:47
Documents
13
Period of Report
2023-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-20230629.htm   iXBRL 8-K 117389
2 EX-10.1 alks-ex10_1.htm EX-10.1 177018
  Complete submission text file 0000950170-23-031901.txt   449026

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alks-20230629_pre.xml EX-101.PRE 11098
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alks-20230629.xsd EX-101.SCH 2474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alks-20230629_lab.xml EX-101.LAB 17722
7 EXTRACTED XBRL INSTANCE DOCUMENT alks-20230629_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 231072132
SIC: 2834 Pharmaceutical Preparations